Pediatric Narcolepsy Cohort to Characterize Sleep, Cognition, and Metabolic Status in Children

Narcolepsy is a rare neurological disorder affecting approximately 0.05% of the general population, characterized by severe sleep-wake dysregulation. Patients experience uncontrolled daytime sleep episodes and disorganized nighttime sleep, primarily due to a loss of hypocretin neurons in the brain. While the core pathology is understood, the specific sleep characteristics, cognitive impacts, and metabolic status in pediatric patients, as well as the long-term effects of current treatments on sleep architecture, remain underexplored. This study aims to fill these critical knowledge gaps.

This planned cohort study will leverage existing patient files from a reference center for narcolepsy to document the disease's characteristics in children. Researchers will analyze data from an estimated 200 pediatric patients, focusing on their sleep characteristics, cognitive performances, and metabolic status. The study will also investigate the effects of various narcolepsy treatments on sleep architecture, utilizing a retrospective analysis of clinical records. The primary goal is to provide a more detailed and comprehensive description of the disease's presentation and treatment responses in this young population.

This record describes a planned cohort study protocol, not a completed study with results. Therefore, no findings are available at this time. The research is scheduled to begin in January 2025 and conclude in January 2026, after which data analysis will commence to identify specific sleep patterns, cognitive profiles, and metabolic parameters in pediatric narcolepsy patients.